Early Therapeutic Intervention in a Child with Beckwith–Wiedemann Syndrome in Inpatient and Outpatient Conditions — Case Report
DOI:
https://doi.org/10.15225/PNN.2019.8.1.4Keywords
Beckwith–Wiedemann syndrome, child health, rare genetic diseases, early intervention, speech therapy, developmental rehabilitationAbstract
Introduction. The Beckwith–Wiedemann syndrome (BWS) is a rare disorder characterized by a wide spectrum of symptoms i.a. umbilical hernia or omphalocele, macroglossia and above-average pre/postnatal growth (macrosomia).
Aim. To present a case report of a child with BWS who underwent an early logopedic intervention and rehabilitation procedures including Bobath neuro-developmental treatment (NDT) and orofacial stimulation based on the Castillo-Morales concept (CMC).
Case Report. The paper presents a case of a girl with BWS and the course of her psychomotor development during the 24 months of her life. The child has numerous defects typical for this syndrome, i.e. facial dysmorphism, macrosomia, and significant hypertrophy of the tongue as well as embryonal carcinomas such as hepatoblastoma and neuroblastoma. Psychomotor development was assessed at the age of 12 months using the Munich Functional Developmental Diagnostics (MFDD). At the age of 2, development of fine and gross motor skills and independence level do not differ significantly from the norm. The biggest problem concerns verbalization of needs due to the enlarged tongue. The girl still remains under multidisciplinary team care and is intensively rehabilitated.
Discussion. There is no doubt that the care of children with BWS requires an interdisciplinary team of specialists. The child needs not only proper physical development, but also correct interpersonal relationships built on verbal communication. Therapy should be started as early as possible before bad habits develop.
Conclusions. The knowledge of clinical features characteristic for the syndrome allows for rapid diagnosis and providing interdisciplinary care since the moment of birth. Children with BWS develop in individual ways depending on the type of genetic cause and additional defects. The care of BWS children must involve permanent and interdisciplinary co-operation with many specialists. (JNNN 2019;8(1):23–29)
References
Beckwith J.B. Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly. Birth Defects Orig Artic Ser. 1969;5(2):188–196.
Wiedemann H.R. Complexe malformatif familial avec hernie ombilicale et macroglossie — un ‘syndrome nouveau’? J Hum Genet. 1964;13:223–232.
Weksberg R., Shuman C., Beckwith J.B. Beckwith–Wiedemann syndrome. Eur J Hum Genet. 2010;18(1):8–14.
Elliott M., Bayly R., Cole T., Temple I.K., Maher E.R. Clinical features and natural history of Beckwith–Wiedemann syndrome: presentation of 74 new cases. Clin Genet. 1994;46(2):168–174.
Rump P., Zeegers M.P., van Essen A.J. Tumor risk in Beckwith–Wiedemann syndrome: A review and meta-analysis. Am J Med Genet A. 2005;136(1):95–104.
Ibrahim A., Kirby G., Hardy C. et al. Methylation analysis and diagnostics of Beckwith–Wiedemann syndrome in 1,000 subjects. Clin Epigenetics. 2014;6(1):11.
Kalish J.M., Biesecker L.G., Brioude F. et al. Nomenclature and definition in asymmetric regional body overgrowth. Am J Med Genet A. 2017.
Maas S.M., Vansenne F., Kadouch D.J. et al. Phenotype, cancer risk, and surveillance in Beckwith–Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A. 2016;170(9):2248–2260.
Mussa A., Russo S., de Crescenzo A. et al. Fetal growth patterns in Beckwith–Wiedemann syndrome. Clin Genet. 2016;90(1):21–27.
Śmigiel R., Misiak B., Sąsiadek M. Zespoły genetyczne charakteryzujące się nadmiernym wzrostem — aspekty kliniczne i poradnictwo genetyczne. Prz Pediatr. 2008;38(2):121–129.
Shuman C., Beckwith J.B., Weksberg R. Beckwith–Wiedemann Syndrome. In: Adam M.P., Ardinger H.H., Pagon R.A. et al. (Ed.), GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle 1993–2019.
Lebiedzińska A., Midro A.T. Genetic counseling in Beckwith–Wiedemann syndrome. Part II. Assessment of probability rate of recurrence of BWS and genetic prognosis. Pediatr Pol. 2008;83(5):535–543.
Reik W., Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2001;2(1):21–32.
Jurkiewicz D., Kugaudo M., Skórka A. et al. A novel IGF2/H19 domain triplication in the 11p15.5 imprinting region causing either Beckwith–Wiedemann or Silver-Russell syndrome in a single family. Am J Med Genet A. 2017;173(1):72–78.
Cooper W.N., Luharia A., Evans G.A. et al. Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome. Eur J Hum Genet. 2005;13(9):1025–1032.
Choufani S., Shuman C., Weksberg R. Beckwith–Wiedemann syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(3):343–354.
Brioude F., Netchine I., Praz F. et al. Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith–Wiedemann Syndrome: Clinical Spectrum and Functional Characterization. Hum Mutat. 2015;36(9):894–902.
Demars J., Rossignol S., Netchine I. et al. New insights into the pathogenesis of Beckwith–Wiedemann and Silver-Russell syndromes: contribution of small copy number variations to 11p15 imprinting defects. Hum Mutat. 2011;32(10):1171–1182.
Reish O., Lerer I., Amiel A. et al. Wiedemann–Beckwith syndrome: further prenatal characterization of the condition. Am J Med Genet. 2002;107(3):209–213.
Clauser L., Tieghi R., Polito J. Treatment of macroglossia in Beckwith–Wiedemann syndrome. J Craniofac Surg. 2006;17(2):369–372.
Kittur M.A., Padgett J., Drake D. Management of macroglossia in Beckwith–Wiedemann syndrome. Br J Oral Maxillofac Surg. 2013;51(1):e6–8.
Matsune K., Miyoshi K., Kosaki R., Ohashi H., Maeda T. Taste after reduction of the tongue in Beckwith–Wiedemann syndrome. Br J Oral Maxillofac Surg. 2006;44(1):49–51.
Wang J., Goodger N.M., Pogrel M.A. The role of tongue reduction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(3):269–273.
Limbrock G.J., Hoyer H., Scheying H. Regulation therapy by Castillo-Morales in children with Down syndrome: primary and secondary orofacial pathology. ASDC J Dent Child. 1990;57(6):437–441.
Castillo-Morales R., Brondo J., Hoyer H., Limbrock G.J. Treatment of chewing, swallowing and speech defects in handicapped children with Castillo-Morales orofacial regulator therapy: advice for pediatricians and dentists. Zahnarztl Mitt. 1985;75(9):935–942, 947–951.
Matthews-Brzozowska T., Kawala B. (Red.), Wpływ wad wrodzonych i nabytych części twarzowej czaszki na mowę. Uniwersytet Medyczny we Wrocławiu, Wrocław 2012.
Boku A., Tachibana K., Shinjo T., Hanamoto H., Takeuchi M., Kinouchi K. Perioperative management of tongue reduction surgery for macroglossia associated with Beckwith–Wiedemann syndrome — A retrospective evaluation of 14 patients. Masui. 2013;62(4):416–420.
Anichini C., Lotti F., Cencini A., Caruso G., Stortini G., Spinelli M. Macroglossia as a Cause of Atypical Swallowing: Comparison of Evaluation and Logopedic Treatment between Beckwith–Wiedemann and Down Patients. J Siena Acad Sci. 2013;5(1):75–79.
Van Borsel J., Morlion B., Van Snick K., Leroy J.S. Articulation in Beckwith–Wiedemann Syndrome: Two Case Studies. Am J Speech Lang Pathol. 2000;9(3):202–213.
Van Lierde K., Galiwango G., Hodges A., Bettens K., Luyten A., Vermeersch H. Impact of tongue reduction on overall speech intelligibility, articulation and oromyofunctional behavior in 4 children with Beckwith–Wiedemann syndrome. Folia Phoniatr Logop. 2012;64(2):55–63.
Narea Matamala G., Fernández Toro Mde L., Villalabeitía Ugarte E., Landaeta Mendoza M. Beckwith Wiedemann syndrome: presentation of a case report. Med Oral Patol Oral Cir Bucal. 2008;13(10):E640–643.
de Lavra-Pinto B., Luz M.J., Motta L., Gomes E. Beckwith–Wiedemann syndrome: case report of speech therapy intervention. Rev CEFAC. 2011;13(2):369–376.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 201
Number of citations: 0